Branaplam is under investigation in clinical trial NCT02268552 (An Open Label Study of LMI070 (Branaplam) in Type 1 Spinal Muscular Atrophy (SMA)).
用于治疗亨廷顿氏病(HD,是一种罕见的遗传性神经退行性疾病)。
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.